Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $811.75 million. The enterprise value is $1.21 billion.
| Market Cap | 811.75M |
| Enterprise Value | 1.21B |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 44.09 million shares outstanding. The number of shares has decreased by -7.65% in one year.
| Current Share Class | 44.09M |
| Shares Outstanding | 44.09M |
| Shares Change (YoY) | -7.65% |
| Shares Change (QoQ) | -1.50% |
| Owned by Insiders (%) | 10.02% |
| Owned by Institutions (%) | 80.22% |
| Float | 32.84M |
Valuation Ratios
The trailing PE ratio is 11.04 and the forward PE ratio is 6.01. AMPH's PEG ratio is 2.85.
| PE Ratio | 11.04 |
| Forward PE | 6.01 |
| PS Ratio | 1.13 |
| Forward PS | 1.05 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 3.80 |
| P/FCF Ratio | 6.00 |
| P/OCF Ratio | 4.81 |
| PEG Ratio | 2.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.11, with an EV/FCF ratio of 8.92.
| EV / Earnings | 15.22 |
| EV / Sales | 1.67 |
| EV / EBITDA | 6.11 |
| EV / EBIT | 8.63 |
| EV / FCF | 8.92 |
Financial Position
The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.89.
| Current Ratio | 3.85 |
| Quick Ratio | 2.73 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 5.08 |
| Interest Coverage | 5.56 |
Financial Efficiency
Return on equity (ROE) is 10.39% and return on invested capital (ROIC) is 9.25%.
| Return on Equity (ROE) | 10.39% |
| Return on Assets (ROA) | 5.34% |
| Return on Invested Capital (ROIC) | 9.25% |
| Return on Capital Employed (ROCE) | 9.43% |
| Weighted Average Cost of Capital (WACC) | 6.48% |
| Revenue Per Employee | $364,641 |
| Profits Per Employee | $40,096 |
| Employee Count | 1,976 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, AMPH has paid $23.59 million in taxes.
| Income Tax | 23.59M |
| Effective Tax Rate | 22.94% |
Stock Price Statistics
The stock price has decreased by -23.80% in the last 52 weeks. The beta is 0.97, so AMPH's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -23.80% |
| 50-Day Moving Average | 20.22 |
| 200-Day Moving Average | 24.92 |
| Relative Strength Index (RSI) | 41.82 |
| Average Volume (20 Days) | 737,859 |
Short Selling Information
The latest short interest is 3.59 million, so 8.13% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.90M |
| Short % of Shares Out | 8.13% |
| Short % of Float | 10.92% |
| Short Ratio (days to cover) | 8.20 |
Income Statement
In the last 12 months, AMPH had revenue of $720.53 million and earned $79.23 million in profits. Earnings per share was $1.67.
| Revenue | 720.53M |
| Gross Profit | 341.13M |
| Operating Income | 139.84M |
| Pretax Income | 102.81M |
| Net Income | 79.23M |
| EBITDA | 197.27M |
| EBIT | 139.84M |
| Earnings Per Share (EPS) | $1.67 |
Balance Sheet
The company has $291.95 million in cash and $686.38 million in debt, with a net cash position of -$394.43 million or -$8.95 per share.
| Cash & Cash Equivalents | 291.95M |
| Total Debt | 686.38M |
| Net Cash | -394.43M |
| Net Cash Per Share | -$8.95 |
| Equity (Book Value) | 773.39M |
| Book Value Per Share | 17.33 |
| Working Capital | 469.21M |
Cash Flow
In the last 12 months, operating cash flow was $168.88 million and capital expenditures -$33.69 million, giving a free cash flow of $135.19 million.
| Operating Cash Flow | 168.88M |
| Capital Expenditures | -33.69M |
| Depreciation & Amortization | 57.43M |
| Net Borrowing | 4.36M |
| Free Cash Flow | 135.19M |
| FCF Per Share | $3.07 |
Margins
Gross margin is 47.34%, with operating and profit margins of 19.41% and 11.00%.
| Gross Margin | 47.34% |
| Operating Margin | 19.41% |
| Pretax Margin | 14.27% |
| Profit Margin | 11.00% |
| EBITDA Margin | 27.38% |
| EBIT Margin | 19.41% |
| FCF Margin | 18.76% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.65% |
| Shareholder Yield | 7.65% |
| Earnings Yield | 9.76% |
| FCF Yield | 16.65% |
Analyst Forecast
The average price target for AMPH is $23.33, which is 26.73% higher than the current price. The consensus rating is "Hold".
| Price Target | $23.33 |
| Price Target Difference | 26.73% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 4.03% |
| EPS Growth Forecast (5Y) | 4.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.44 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 5 |